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Abstract
Obesity is a widespread problem across the leisure population of horses and ponies in industrialised nations. Skeletal
muscle is a major contributor to whole body resting energy requirements and communicates with other tissues through the
secretion of myokines into the circulation. Myostatin, a myokine and negative regulator of skeletal muscle mass, has been
implicated in obesity development in other species. This study evaluated gene and protein expression of myostatin and its
receptor, ActRIIB in adipose tissues and skeletal muscles and serum myostatin concentrations in six lean and six obese
animals to explore putative associations between these factors and obesity in horses and ponies. Myostatin mRNA
expression was increased while ActRIIB mRNA was decreased in skeletal muscles of obese animals but these differences
were absent at the protein level. Myostatin mRNA was increased in crest fat of obese animals but neither myostatin nor
ActRIIB proteins were detected in this tissue. Mean circulating myostatin concentrations were significantly higher in obese
than in lean groups; 4.98 ng/ml (62.71) and 9.00 ng/ml (62.04) for the lean and obese groups, respectively. In addition,
there was a significant positive association between these levels and myostatin gene expression in skeletal muscles (average
R2 = 0.58; p,0.05). Together, these results provide further basis for the speculation that myostatin and its receptor may play
a role in obesity in horses and ponies.
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Introduction
Epidemiological studies continue to report a high prevalence of
obesity amongst the leisure population of horses and ponies in the
UK [1,2]. The well-documented negative impacts of obesity on
health and performance have led to obesity being considered one
of the major welfare issues in horses and ponies facing
industrialised nations today [3]. Obese animals are at an increased
risk of developing insulin dysregulation and the severely painful
and often life-threatening condition, laminitis, although the precise
mechanisms linking these conditions are not yet fully understood.
The organ systems involved in energy homeostasis work in
synergy to achieve the maintenance of whole body energy balance.
As the largest metabolically active tissue in the body (comprising
around 40% body mass, [4,5]), skeletal muscle is a key
determinant of resting energy expenditure and therefore plays a
vital role in maintaining energy balance. Communication with
other organs, including adipose tissue, is achieved through the
secretion of molecular messengers into the circulation, termed
myokines. Myostatin, a member of the transforming growth factor
b (TGFb) family of secreted growth factors, is one such myokine.
The initial studies showed that mice lacking the myostatin gene
were extremely hypermuscular and had minimal body fat when
compared to their wild-type counterparts [6]. To date, myostatin
has been widely characterised as a potent negative regulator of
skeletal muscle mass [7–9] and methods to inhibit myostatin
function as a potential therapeutic treatment for increasing muscle
mass in diseases such as muscular dystrophy and cancer cachexia
have been explored [10,11].
Myostatin is synthesised as an inactive precursor protein which
subsequently undergoes two cleavages to produce the mature,
active form of the protein. Mature myostatin is bound noncova-
lently to its propeptide and circulates in serum as an inactive
complex [12]. Active, mature myostatin binds selectively to the
activin type II receptor kinase, ActRIIB. Studies in rodents and
humans generally report that myostatin expression levels are
highest in skeletal muscle, although it has also been identified in
adipose tissue [6]. Previous work from this laboratory supports
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these findings and extends them to the horse. These data
confirmed that myostatin gene and precursor protein expression
is greatest in skeletal muscles and that in the horse, although low
levels of expression were detected in adipose tissue at the gene
level, myostatin precursor protein was absent [13].
Work in murine models and humans has identified that
myostatin may have an important role in obesity development.
Myostatin knock-out (KO) mice offered high-fat diets are resistant
to gains in body fat [14,15], and although this effect may be
secondary to the increases in lean body mass, myostatin had direct
effects on adipocyte differentiation [16,17]. Furthermore, blocking
myostatin increased the functional capacity of brown adipose
tissue (BAT) [18] and may even drive the browning of white
adipose tissue through the up-regulation of BAT-specific genes
[19]. Myostatin gene expression was positively associated with
obesity in both mouse [20] and human studies [21], whilst
blocking myostatin function in mature mice elicited positive effects
on glucose and insulin dynamics [22]. In comparison to human
and rodent studies, there are fewer studies of myostatin in horses
and ponies, and the extant reports generally focus on the
identification of a number of single nucleotide polymorphisms
(SNP’s) in the myostatin gene. SNPs have been associated with
different attributes including breeds of different morphological
type [23], optimal race distance in Thoroughbred horses [24] and
skeletal muscle fibre type proportions in Quarter horses [25].
To date, no work has been conducted to characterize the
expression myostatin and its receptor against the setting of obesity
in the horse or pony. The current study was designed to explore
possible differences in myostatin and ActRIIB expression between
lean and obese animals by quantifying myostatin and ActRIIB
gene and protein expression in skeletal muscle and adipose tissue,
and measuring serum myostatin concentrations.
Methods
Animals and tissue collection
Although animal procedures did not constitute an experiment as
defined under the Animals (Scientific Procedures) Act 1986, all
work was approved by the University of Liverpool’s Veterinary
Research Ethics Committee. Tissues from six lean (body condition
score (BCS)/9= 3.0760.50, where 1= emaciated and 9=obese
[26]) and six obese (BCS/9= 7.760.46) mature, mixed breed
horses and ponies were obtained post-mortem. All animals were in
good general health and were euthanased for reasons unrelated to
this study (Table 1). The horses were slaughtered in a commercial
abattoir (LJ Potters, Taunton, Somerset) in accordance with EU
legislations EC 852/2004, 853/2004 and 854/2004 on several
dates between March 2013 and January 2014. Ante-mortem data
collection included BCS (/9, [26]), breed type, gender, estimated
withers height and age. For assessment of BCS, six areas of the
body (neck, withers, loin, tailhead, ribs and shoulder) are assigned
a number from 1 (emaciated) to 9 (obese) based on detailed
descriptors. The average of these six numbers is calculated and this
number equates to the final BCS score for the animal [26].
To evaluate gene and protein expression of myostatin and
ActRIIB, a total of five anatomically-discrete adipose depots and
four functionally distinct skeletal muscles were sampled. Strict
anatomical descriptors were used to ensure that tissue samples
were collected from the same site in each animal (Table 2). Tissue
samples were obtained as rapidly as possible post-mortem (adipose
tissues within 30 minutes; skeletal muscles within 1 hour) using
sterile equipment, as recommended previously [13]. All samples
were minced with scissors and snap frozen in liquid nitrogen
before being stored at 280uC pending RNA and protein
extraction. For the measurement of myostatin protein in serum,
blood samples (,10 ml) were collected into plain tubes (BD
Vacutainer) at exanguination and allowed to clot before centri-
fuging at 2000 g for 10 minutes at 4uC. Serum was collected and
stored at 220uC pending myostatin protein measurement by
ELISA.
RNA extraction
Total RNA was extracted from all frozen tissue samples using
TRIzol reagent (Invitrogen, Paisley, UK), in accordance with the
manufacturers protocol. RNA concentration and purity was
quantified spectrophotometrically (Eppendorf Biophotometer,
Hamburg, Germany) and all optical density A260/280 ratios
were within acceptable ranges (1.7–2.0). Reverse transcription
(RT) was carried out in a 10 ml final reaction volume containing
0.5 mg RNA using an iScript cDNA synthesis kit (Bio-Rad Hemel
Hempstead, UK). The resulting cDNA was diluted at 1:4 and used
as a template for real-time PCR analysis.
Quantitative Real-Time PCR
The expression of myostatin, ActRIIB and four housekeeping
genes previously used in other studies in horses and ponies [27,28]
(GAPDH, Beta-actin, HPRT1 and RPL32) was determined in all
tissues from the twelve animals. GeNorm software (GenEx,
Germany) was used to assess the two ‘most stably’ expressed
genes to be used for normalisation. Gene expression was
determined by quantitative real-time PCR performed in duplicate
using the Stratagene Mx3005P detection system (Agilent Tech-
nologies, California USA). Primer sequences for all four house-
keeping genes were obtained from previously published data
(HPRT1 and RPL32, GAPDH [28], and beta-actin [27]) and
100% homology was confirmed by performing a basic local
alignment search tool (BLAST). Primer and Taqman probe
sequences for myostatin and ActRIIB, were designed using Beacon
Designer (Premier Biosoft, USA). All primers were designed to be
exon-spanning. All primer/probe sets were purchased from
Eurogentec (Belgium) (Table 3). Serial dilutions of pooled cDNA
were used to calculate Taqman primer efficiencies. The PCR
cycling conditions (using Taqman probe and primers) for
myostatin and ActRIIB were as follows: 10 minutes at 95uC,
followed by 40 cycles of 30 seconds at 95uC, 1 minute at 55uC and
1 minute at 72uC. Cycling conditions for housekeeping genes
(using SYBR green method) were as follows: 10 minutes at 95uC
followed by 40 cycles of 15 seconds at 95uC and 30 seconds at
60uC and ending with, 1 minute at 95uC, 30 seconds at 55uC and
30 seconds at 95uC.
Relative gene expression was calculated using the comparative
Ct method (22DCt) [29]. All gene expression data were normalised
to 2 internal housekeeping genes.
Protein Extraction and Western Blotting
Soluble protein was extracted from frozen tissues by homoge-
nising around 100 mg of tissue in a SHE buffer (250 mM sucrose,
1 mM HEPES, 0.2 mM EDTA) containing both phosphatase and
protease inhibitor cocktails (both Sigma, Poole, Dorset, UK).
Samples were centrifuged and the soluble fraction was used for
determining protein concentration by the bicinchoninic acid
(BCA) method [30].
Thirty micrograms of protein extract were separated on 10%
SDS-polyacrylamide gels under reducing conditions and proteins
were transferred onto nitrocellulose membranes (Hybond-C Extra,
Amersham Bioscience, Buckinghamshire, UK) by electroblotting
(Turbo transfer, BioRad). Membranes were stained in Ponceau S
reversible stain to verify the success of protein transfer and then
Myostatin System and Equine Obesity
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blocked for 1 hour in 5% BSA in Tris-buffered saline containing
0.1% Tween 20 (TBST). Commercially available primary
antibodies (listed below) were used and were selected on the basis
that they were listed as having ‘equine cross-reactivity’. They were
added at the following concentrations: myostatin precursor
(MSTN), 1:2500 [ab98337 Abcam, Cambridge, UK], myostatin
receptor (ACTRIIB), 1:2000 [sc-25453 Santa Cruz, Dallas, Texas,
USA] and the serine/threonine Akt (AKT), 1:3000 [#9272 Cell
Signalling, Danvers, MA, USA]) in blocking buffer and incubated
overnight at 4uC. The myostatin antibody detected the precursor
form of the protein (,43 kDa). The membranes were washed and
then incubated for 1 hour with a secondary antibody (Cell
Signalling) at appropriate concentrations. Signals were detected by
chemiluminescence using a SuperSignal West Pico Chemilumi-
nescent Substrate (Pierce, Rockford, IL, US) and visualised and
quantified on a Molecular Imager ChemiDoc XRS+ System (Bio-
Rad). The results were normalised to the value of AKT. To ensure
the reliability of data, western blots for myostatin and ActRIIB
proteins in skeletal muscles were repeated three times and average
densitometric values were calculated.
Myostatin ELISA
Mature myostatin protein concentration was measured using a
commercially available ELISA kit (R&D Systems, Catalogue
number: DGDF80) which has been validated for use on ‘equine
serum and plasma samples’ by R&D systems (www.rndsystems.
com/pdf/DGDF80.pdf) and employs the quantitative sandwich
enzyme immunoassay technique to measure mature myostatin
concentration. Prior to running the plate, samples were subjected
to acid activation and neutralisation to remove the pro-peptide
from myostatin. Samples were run in duplicate and the ELISA was
run according to the manufacturer’s protocol. Myostatin concen-
tration (ng/ml) was calculated from a standard curve.
Table 1. Phenotypic descriptors for the animals used in this study.
Horse ID Gender Age (years) BCS (/9) Breed type
Lean 1 Gelding 8 3 Welsh Pony
2 Mare 5 3.8 Welsh Pony
3 Gelding 15 2.5 Sport horse
4 Gelding 6 3 Sport horse
5 Mare 10 3.5 Sport horse
6 Gelding 4 2.6 Sport horse
Obese 7 Mare 6 7 Cob horse
8 Mare 13 8 Cob pony
9 Mare 5 7.3 Sport horse
10 Gelding 15 8.2 Cob pony
11 Gelding 7 7.9 Cob pony
12 Mare 15 7.8 Cob horse
Body condition score (BCS), age and gender are indicated. Breed types are as denoted in animal passports and/or confirmed by visual inspection. The term ‘cob’ denotes
a small horse (.148 cm withers height) or large pony (,148 cm) with characteristically ‘heavy’ skeletal conformation. Sport horse is used to indicate animals of lighter
type with Thoroughbred or Warmblood influenced conformation.
doi:10.1371/journal.pone.0112621.t001
Table 2. Specific anatomical descriptors used to locate the tissue collection points for the 5 regionally discrete adipose tissue
depots and 4 skeletal muscles sampled from horses used in the current study.
Tissue Anatomical descriptors for sample sites
Adipose
tissues
Ventro-abdominal ,3 cm3, collected from the left split-carcass midline at a point equidistant between xiphisternum and pubis.
Epicardial ,2 cm3 from the coronary groove and overlying the left coronary artery
Omental Variable area of omentum, sufficient to harvest ,2 cm3 of adipose tissue, from a region adjoining the greater curvature of the
stomach and bearing visible adipose.
Crest ,3 cm3 from the left split-carcass at the deepest part of the crest, midway between wither and poll extremities.
Tailhead ,2 cm3 from the subcutaneous adipose tissue overlying the gluteal muscles of the left carcass.
Skeletal
muscles
Rectus abdominis, ,3 cm3, collected from the left split-carcass midline at a point equidistant between xiphisternum and pubis.
Longus colli, ,3 cm3, from its severed cranial extremity in the left split-carcass.
Pectoralis transversus ,3 cm3, collected from the exposed midline section of the muscle at a point just ,10 cm caudal to the thoracic inlet.
Pectoralis profoundus ,3 cm3, collected from the exposed midline section of the muscle, immediately deep to the collection site for Pectoralis
transversus.
Approximate target sample sizes are given. Where relevant, tissues were collected from the left side following carcass-splitting.
doi:10.1371/journal.pone.0112621.t002
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Statistical Analysis
Statistical analyses were performed using STATA version 12.1.
Non-parametric, analytical methods were employed to assess gene
and protein expression data. The Kruskal Wallis test was used to
assess differences in gene and protein expression, along with
differences in circulating myostatin concentrations between lean
and obese animals. Associations between circulating myostatin and
myostatin plus ActRIIB gene and protein expression were
analysed using linear regression. Significance was set at p,0.05.
Results
Animals
The animals used in this study were slaughtered in a
commercial abattoir for non-research purposes. The BCS in the
population fell within the commercial range and lean and obese
BCS categories were selected to give clear differences in body fat
content [31].
Myostatin and ActRIIB gene expression
Myostatin gene expression across all skeletal muscles studied
was significantly greater in the obese animals compared to the lean
animals (p,0.05) (Figure 1a). In contrast, ActRIIB gene expres-
sion was significantly lower in obese animals in three out of the
four skeletal muscles studied (p,0.05) (Figure 1b). While myosta-
tin gene expression was considerably lower in adipose tissues in
comparison to skeletal muscles, expression was significantly greater
in the crest fat of obese animals compared with lean animals (p,
0.05) (Figure 2a). No difference was observed between lean and
obese animals for ActRIIB gene expression in adipose tissues
(Figure 2b).
Myostatin and ActRIIB protein expression
Myostatin precursor protein expression was quantified across
the four skeletal muscles by western blotting in three separate
experiments. Although the average densitometric data showed no
significant differences between lean and obese animals for any
skeletal muscle studied (Pectoralis transversus, p = 0.75; Longus
colli, p = 0.42; Rectus abdominis, p = 0.26; Pectoralis profoundus,
p = 0.08), obese animals tended to have greater myostatin protein
expression compared with lean animals (Figure 3). Similarly
ActRIIB protein expression was quantified across the four skeletal
muscles by western blotting in three separate experiments. No
significant differences in protein expression between lean and
obese animals were observed in the skeletal muscles studied
(Figure 4). Due to the differences observed at the gene level in
crest fat for myostatin, we sought to identify whether these
differences were translated into differences at the protein level for
both myostatin and ActRIIB. However, Figure 5 clearly demon-
strates there was no protein detected in either the lean or obese
animals for myostatin or ActRIIB.
Circulating myostatin concentration
Circulating, mature myostatin protein was detected in serum
samples from all animals studied. Overall, mean serum myostatin
concentration was 6.99 ng/ml (63.10); the range was 2.72 ng/ml
to 11.40 ng/ml. The mean values for the lean and obese groups
were 4.98 ng/ml (62.71) and 9.00 ng/ml (62.04), respectively.
Kruskal Wallis test revealed significant differences between lean
and obese animals (p,0.05) (Figure 6). Univariate analysis
revealed positive associations between serum myostatin concen-
trations and myostatin mRNA expression in skeletal muscle for all
muscles studied, irrespective of whether muscles were considered
independently or collectively (average R2= 0.58, p,0.05) (Ta-
ble 4). Associations between myostatin serum concentrations and
the magnitude of muscle myostatin protein expression were
weaker than those recorded for gene expression (average
R2= 0.28). Only myostatin protein expression in Pectoralis
profoundus had a significant association with serum myostatin
concentration (R2 = 0.50, p = 0.01) (Table 4). No associations were
identified between myostatin serum concentration and ActRIIB
gene or protein expression (Table 4).
Discussion
This study presents preliminary data which provide the first
indication of a possible association between BCS and myostatin
gene expression and secretion in horses and ponies.
The increased gene expression of myostatin in skeletal muscles
of obese animals is in agreement with similar data for mice where
Table 3. Nucleotide sequences of primers and probes used in the current study.
Gene Primer Sequence Amplification efficiency
Beta-actin Forward GGACCTGACGGACTACCTC 97%
Reverse CACGCACGATTTCCCTCTC
HPRT1 Forward GGCAAAACAATGCAAACCTT 94.5%
Reverse CAAGGGCATATCCTACGACAA
GAPDH Forward CAGAACATCATCCCTGCTTC 95%
Reverse ATGCCTGCTTCACCACCTTC
RPL32 Forward AGCCATCTACTCGGCGTCA 94%
Reverse TCCAATGCCTCTGGGTTTC
Myostatin Forward GCAGTGATGGCTCTTTGGAAG 97.9%
Reverse GCATTAGAAGATCAGACTCTGTAGG
Probe ACCACGCGACGACGGAAACAATCAT
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Figure 1. Gene expression of Myostatin and ActRIIB in skeletal muscles of lean and obese horses and ponies. Gene expression was
analysed by real-time PCR and the geometric mean of the two most stable housekeeping genes as determined by GeNorm (GAPDH and beta-actin)
was used for normalisation. Relative transcript abundance is shown for Myostatin (A) and ActRIIB (B). *denotes where values differ significantly (p,
0.05) from lean group. n = 6/group.
doi:10.1371/journal.pone.0112621.g001
Figure 2. Gene expression of Myostatin and ActRIIB in adipose tissues of lean and obese horses and ponies. Gene expression was
analysed by real-time PCR and the geometric mean of the two most stable housekeeping genes as determined by GeNorm (RPL32 and beta-actin)
was used for normalisation. Relative transcript abundance is shown for Myostatin (A) and ActRIIB (B). *denotes where values differ significantly (p,
0.05) from lean group. n = 6/group.
doi:10.1371/journal.pone.0112621.g002
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Figure 3. Protein expression of Myostatin precursor protein in skeletal muscles of lean and obese horses and ponies. Protein
expression of myostatin precursor protein (,45 kDa) was assessed by Western blot with total AKT used as a loading control. Mean densitometric
signals were calculated from three independently repeated Western blots. n = 6/group.
doi:10.1371/journal.pone.0112621.g003
Figure 4. Protein expression of ActRIIB protein in skeletal muscles of lean and obese horses and ponies. Protein expression of ActRIIB
protein (,50 kDa) was assessed by Western blot with total AKT used as a loading control. Mean densitometric signals were calculated from three
independantly repeated Western blots. n = 6/group.
doi:10.1371/journal.pone.0112621.g004
Myostatin System and Equine Obesity
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myostatin mRNA levels were significantly greater in tibialis
anterior muscle in ob/ob mice compared to wild-type mice [20].
In that study [20], the expression of ActRIIB was not different
between lean and obese animals for skeletal muscle, whereas in the
current study, ActRIIB mRNA was significantly down-regulated
in three out of the four skeletal muscles studied. This may be
suggestive of some element of negative feedback regulation
between myostatin and ActRIIB.
Increased expression of myostatin protein has been identified in
the vastus lateralis muscle from extremely obese human subjects
(BMI $40 kg/m2) [21]. Perhaps the lack of statistical significance
observed in the current study may be due to absolute differences in
body fat content between species. Obese horses and ponies were
found to have up to 30% body fat recorded in a previous study
[32], which is considerably lower than the body fat content of
morbidly obese humans which was found to average 48.5% [33].
The finding of altered myostatin and ActRIIB mRNA expression
in muscle without parallel changes in protein expression has
previously been shown [34,35]. It is known that the mRNA
expression of a particular gene is not always predictive of protein
expression, and the correlation between the two can vary
significantly [36]. There are several possible explanations for the
differences between the gene and protein expression including
variation in protein half-lives, complex post-transcriptional mech-
anisms, and different sensitivities in methodologies for detecting
mRNA and protein expressions [37].
Circulating concentrations of myostatin were significantly
higher in obese than in lean animals in the current study. This
is consistent with previous observations of increased myostatin
secretion from myotubes derived from muscle of extremely obese
humans [21]. In the current study there was one clear outlier in
our lean group of animals for both circulating concentrations and
mRNA expression of myostatin which upon investigation was
found to be the Welsh pony mare (Horse 2; Table 1). It could be
speculated that this may be indicative of an increased propensity
towards obesity based on a finding from a murine study in which
obesity-susceptible strain of mice (C57BL/6) had increased mRNA
expression of myostatin in skeletal muscle compared to an obesity-
resistant strain of mice, SWR/J [38].
Myostatin gene expression was generally low in adipose tissues
but was significantly higher in crest fat from obese than lean
animals. Increased fat deposition in this subcutaneous fat depot
along the nuchal crest of the neck in horses and ponies has been
associated with laminitis risk [39], hyperinsulinemia [40], and has
been proposed to be an important source of proinflammatory
cytokines [41]. Differences in myostatin gene expression between
Figure 5. Protein expression of Myostatin precursor and ActRIIB proteins in crest fat of lean and obese horses and ponies. Protein
expression of myostatin precursor protein and ActRIIB was assessed by Western blot with total AKT used as a loading control. Blots are shown for
crest fat expression across all animals with a skeletal muscle sample used as positive control. n = 6/group.
doi:10.1371/journal.pone.0112621.g005
Table 4. Univariate regression analysis results for myostatin ELISA data.
Variable Coefficient Adjusted R2 95% CI P value
Myostatin gene
expression
Rectus abdominis 1287.62 0.65 622.89 to 1952.35 0.002
Longus colli 1179.68 0.54 409.69 to 1949.68 0.007
Pectoralis profoundus 2811.07 0.78 1761.03 to 3861.11 ,0.001
Pectoralis transversus 836.77 0.36 57.41 to 1616.13 0.04
ActRIIB gene
expression
Rectus abdominis 2201.53 0.01 22083.14 to 1680.08 0.82
Longus colli 2583.66 0.23 21336.72 to 169.40 0.12
Pectoralis profoundus 21332.49 0.32 22710.86 to 45.89 0.06
Pectoralis transversus 25812.13 0.33 212115.38 to 491.11 0.07
Myostatin protein
expression
Rectus abdominis 7.28 0.13 26.17 to 20.74 0.26
Longus colli 5.36 0.26 20.95 to 11.67 0.09
Pectoralis profoundus 16.40 0.50 4.81 to 27.99 0.01
Pectoralis transversus 12.58 0.24 23.39 to 28.54 0.11
ActRIIB protein
expression
Rectus abdominis 28.91 0.15 223.98 to 6.15 0.22
Longus colli 1.43 0.004 213.84 to 16.71 0.84
Pectoralis profoundus 10.35 0.25 22.37 to 23.08 0.10
Pectoralis transversus 6.80 0.17 23.62 to 17,23 0.17
Myostatin concentration was the outcome variable and BCS, myostatin and ActRIIB gene and protein expression data for the individual skeletal muscles was offered as
explanatory variables.
doi:10.1371/journal.pone.0112621.t004
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crest fat samples from lean and obese animals were not reflected in
protein expression in this tissue. Data indicated that neither
myostatin precursor nor ActRIIB proteins were detectable in the
crest fat of either lean or obese animals by the methods used in the
current study. This is in agreement with data presented in an
earlier study which similarly failed to detect either myostatin
precursor or ActRIIB proteins in crest and other adipose tissues
from lean (BCS,4/9) animals [13].
These preliminary data offer some evidence that the ‘myostatin
system’ may differ at both the gene and protein level in lean and
obese horses and ponies. Further work is needed, and these
findings now provide the basis for future prospective studies in
horses and ponies to explore the previous speculation from human
studies [21] that circulating myostatin levels and/or associated
factors might act as biological marker(s) for metabolic conditions
including obesity.
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